Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 3
2006 1
2008 2
2009 1
2010 1
2011 1
2012 4
2013 2
2014 4
2015 1
2016 2
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.
Akinrinmade OA, Chetty S, Daramola AK, Islam MU, Thepen T, Barth S. Akinrinmade OA, et al. Among authors: thepen t. Biomedicines. 2017 Sep 12;5(3):56. doi: 10.3390/biomedicines5030056. Biomedicines. 2017. PMID: 28895912 Free PMC article. Review.
Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.
Hristodorov D, Mladenov R, Huhn M, Barth S, Thepen T. Hristodorov D, et al. Among authors: thepen t. Toxins (Basel). 2012 Sep;4(9):676-94. doi: 10.3390/toxins4090676. Epub 2012 Sep 14. Toxins (Basel). 2012. PMID: 23105975 Free PMC article. Review.
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.
Mladenov R, Hristodorov D, Cremer C, Gresch G, Grieger E, Schenke L, Klose D, Amoury M, Woitok M, Jost E, Brümmendorf TH, Fendel R, Fischer R, Stein C, Thepen T, Barth S. Mladenov R, et al. Among authors: thepen t. Oncotarget. 2016 Oct 11;7(41):67166-67174. doi: 10.18632/oncotarget.11568. Oncotarget. 2016. PMID: 27564103 Free PMC article.
Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.
Hristodorov D, Mladenov R, Fischer R, Barth S, Thepen T. Hristodorov D, et al. Among authors: thepen t. Immunol Cell Biol. 2016 May;94(5):470-8. doi: 10.1038/icb.2016.4. Epub 2016 Jan 8. Immunol Cell Biol. 2016. PMID: 26743033
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein.
Hristodorov D, Amoury M, Mladenov R, Niesen J, Arens K, Berges N, Hein L, Di Fiore S, Pham AT, Huhn M, Helfrich W, Fischer R, Thepen T, Barth S. Hristodorov D, et al. Among authors: thepen t. Mol Cancer Ther. 2014 Sep;13(9):2194-202. doi: 10.1158/1535-7163.MCT-13-0781. Epub 2014 Jun 30. Mol Cancer Ther. 2014. PMID: 24980949 Free article.
Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D, Mladenov R, Brehm H, Fischer R, Barth S, Thepen T. Hristodorov D, et al. Among authors: thepen t. MAbs. 2014;6(5):1283-9. doi: 10.4161/mabs.32182. MAbs. 2014. PMID: 25517313 Free PMC article.
Reduction of activated macrophages after ischaemia-reperfusion injury diminishes oxidative stress and ameliorates renal damage.
Fet NG, Fiebeler A, Klinge U, Park JK, Barth S, Thepen T, Tolba RH. Fet NG, et al. Among authors: thepen t. Nephrol Dial Transplant. 2012 Aug;27(8):3149-55. doi: 10.1093/ndt/gfr792. Epub 2012 Mar 8. Nephrol Dial Transplant. 2012. PMID: 22402584
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies.
Hristodorov D, Mladenov R, von Felbert V, Huhn M, Fischer R, Barth S, Thepen T. Hristodorov D, et al. Among authors: thepen t. MAbs. 2015;7(5):853-62. doi: 10.1080/19420862.2015.1066950. MAbs. 2015. PMID: 26218624 Free PMC article.
Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
Schiffer S, Letzian S, Jost E, Mladenov R, Hristodorov D, Huhn M, Fischer R, Barth S, Thepen T. Schiffer S, et al. Among authors: thepen t. Cancer Lett. 2013 Dec 1;341(2):178-85. doi: 10.1016/j.canlet.2013.08.005. Epub 2013 Aug 22. Cancer Lett. 2013. PMID: 23973499
Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.
Schiffer S, Rosinke R, Jost E, Hehmann-Titt G, Huhn M, Melmer G, Barth S, Thepen T. Schiffer S, et al. Among authors: thepen t. Int J Cancer. 2014 Sep 15;135(6):1497-508. doi: 10.1002/ijc.28786. Epub 2014 Mar 18. Int J Cancer. 2014. PMID: 24523193 Free article.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback